Tolerance Induction by Exosomes from Immature Dendritic Cells and Rapamycin in a Mouse Cardiac Allograft Model

PLoS ONE

Volumn 7, Issue 8, 2012, Pages

  Li, Xiao ^a   Li, Jun Jie ^a   Yang, Jing Yue ^a   Wang, De Sheng ^a   Zhao, Wei ^a   Song, Wen Jie ^a   Li, Wei Min ^a   Wang, Jian Feng ^a   Han, Wei ^a   Zhang, Zhuo Chao ^a   Yu, Yong ^a   Cao, Da Yong ^a   Dou, Ke Feng ^a  

^a FOURTH MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; RAPAMYCIN; TRANSCRIPTION FACTOR FOXP3;

ACUTE GRAFT REJECTION; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CARDIAC GRAFT REJECTION; CD4+ CD25+ T LYMPHOCYTE; CELLULAR IMMUNITY; CONTROLLED STUDY; DENDRITIC CELL; EXOSOME; GRAFT SURVIVAL; HEART TRANSPLANTATION; IMMUNOLOGICAL TOLERANCE; IN VITRO STUDY; IN VIVO STUDY; LOW DRUG DOSE; LYMPHOCYTE PROLIFERATION; MALE; MOUSE; NONHUMAN; SPLEEN CELL; T LYMPHOCYTE ACTIVATION;

ANIMALS; ANTIGENS; BLOTTING, WESTERN; CD4-POSITIVE T-LYMPHOCYTES; CELL DIFFERENTIATION; CELL PROLIFERATION; DENDRITIC CELLS; DOSE-RESPONSE RELATIONSHIP, DRUG; EXOSOMES; FLOW CYTOMETRY; GRAFT REJECTION; GRAFT SURVIVAL; HEART TRANSPLANTATION; IMMUNE TOLERANCE; IMMUNOSUPPRESSIVE AGENTS; INTERLEUKIN-2 RECEPTOR ALPHA SUBUNIT; LYMPHOCYTE ACTIVATION; MALE; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MODELS, ANIMAL; SIROLIMUS; SPLEEN; TRANSPLANTATION, HOMOLOGOUS;

EID: 84865580434     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0044045     Document Type: Article

References (34)

1. Wood KJ, Goto R, (2010) Mechanisms of rejection: current perspectives. Transplantation 93: 1-10.
2. Schonder KS, (2011) Pharmacology of immunosuppressive medications in solid organ transplantation. Crit Care Nurs Clin North Am 23: 405-423.
3. Mendieta-Zerón H, (2011) Developing immunologic tolerance for transplantation at the fetal stage. Immunotherapy 3: 1499-1512.
4. Morelli AE, (2006) The immune regulatory effect of apoptotic cells and exosomes on dendritic cells: its impact on transplantation. Am J Transplant 6: 254-261.
5. van Kooten C, Lombardi G, Gelderman KA, Sagoo P, Buckland M, et al. (2011) Dendritic cells as a tool to induce transplantation tolerance: obstacles and opportunities. Transplantation 91: 2-7.
6. Chaput N, Théry C, (2011) Exosomes: immune properties and potential clinical implementations. Semin Immunopathol 33: 419-440.
7. Admyre C, Johansson SM, Paulie S, Gabrielsson S, (2006) Direct exosome stimulation of peripheral human T cells detected by ELISPOT. Eur J Immunol 36: 1772-1781.
8. Montecalvo A, Shufesky WJ, Stolz DB, Sullivan MG, Wang Z, et al. (2008) Exosomes as a short-range mechanism to spread alloantigen between dendritic cells during T cell allorecognition. J Immunol 180: 3081-3090.
9. Segura E, Nicco C, Lombard B, Véron P, Raposo G, et al. (2005) ICAM-1 on exosomes from mature dendritic cells is critical for efficient naive T cell priming. Blood 106: 216-223.
10. Bianco NR, Kim SH, Ruffner MA, Robbins PD, (2009) Therapeutic effect of exosomes from indoleamine 2, 3-dioxygenase-positive dendritic cells in collagen-induced arthritis and delayed-type hypersensitivity disease models. Arthritis Rheum 60: 380-389.
11. Kim SH, Bianco NR, Shufesky WJ, Morelli AE, Robbins PD, (2007) Effective treatment of inflammatory disease models with exosomes derived from dendritic cells genetically modified to express IL-4. J Immunol 179: 2242-2249.
12. Yang X, Meng S, Jiang H, Chen T, Wu W, (2010) Exosomes derived from interleukin-10-treated dendritic cells can inhibit trinitrobenzene sulfonic acid-induced rat colitis. Scand J Gastroenterol 45: 1168-1177.
13. Yang X, Meng S, Jiang H, Zhu C, Wu W, (2011) Exosomes derived from immature bone marrow dendritic cells induce tolerogenicity of intestinal transplantation in rats. Surg Res 171: 826-832.
14. Pêche H, Heslan M, Usal C, Amigorena S, Cuturi MC, (2003) Presentation of donor major histocompatibility complex antigens by bone marrow dendritic cell-derived exosomes modulates allograft rejection. Transplantation 76: 1503-1510.
15. Pêche H, Trinite B, Martinet B, Cuturi MC, (2005) Prolongation of heart allograft survival by immature dendritic cells generated from recipient type bone marrow progenitors. Am J Transplant 5: 255-267.
16. Lutz MB, Kukutsch N, Ogilvie AL, Rössner S, Koch F, et al. (1999) An advanced culture method for generating large quantities of highly pure dendritic cells from mouse bone marrow. J Immunol Methods 223: 77-92.
17. Lamparski HG, Metha-Damani A, Yao JY, Patel S, Hsu DH, et al. (2002) Production and characterization of clinical grade exosomes derived from dendritic cells. J Immunol Methods 270: 211-226.
18. Hackstein H, Taner T, Zahorchak AF, Morelli AE, Logar AJ, et al. (2003) Rapamycin inhibits IL-4-induced dendritic cell maturation in vitro and dendritic cell mobilization and function in vivo. Blood 101: 4457-4463.
19. Taner T, Hackstein H, Wang Z, Morelli AE, Thomson AW, (2005) Rapamycin-treated, alloantigen-pulsed host dendritic cells induce Ag-specific T cell regulation and prolong graft survival. Am J Transplant 5: 228-236.
20. Turnquist HR, Cardinal J, Macedo C, Rosborough BR, Sumpter TL, et al. (2010) mTOR and GSK-3 shape the CD4+ T-cell stimulatory and differentiation capacity of myeloid DCs after exposure to LPS. Blood 115: 4758-4769.
21. Pliszczynski J, Kahan BD, (2011) Better actual 10-year renal transplant outcomes of 80% reduced cyclosporine exposure with sirolimus base therapy compared with full cyclosporine exposure without or with concomittant sirolimus treatment [J]. Transplant Proc 43: 3657-3668.
22. Inaba K, Inaba M, Romani N, et al. (1992) Generation of large numbers of dendritic cells from mouse bone marrow cultures supplemented with granulocytermacrophage colonystimulating factor. J Exp Med 176: 1693-1702.
23. Sallusto F, Lanzavecchia A, (1994) Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocytermacrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha. J Exp Med 179: 1109-1118.
24. Hume PS, He J, Haskins K, Anseth KS, (2012) Strategies to reduce dendritic cell activation through functional biomaterial design. Biomaterials 33: 3615-3625.
25. Morse MA, Garst J, Osada T, Khan S, Hobeika A, et al. (2005) A phase I study of dexosome immunotherapy in patients with advanced non-small cell lung cancer. J Transl Med 3: 9-9.
26. Kim SH, Lechman ER, Bianco N, Menon R, Keravala A, et al. (2005) Exosomes derived from IL-10-treated dendritic cells can suppress inflammation and collagen-induced arthritis. J Immunol 174: 6440-6448.
27. Battaglia M, Stabilini A, Roncarolo MG, (2005) Rapamycin selectively expands CD4+CD25+FoxP3+ regulatory T cells. Blood 105: 4743-4748.
28. Monti P, Scirpoli M, Maffi P, Piemonti L, Secchi A, et al. (2008) Rapamycin monotherapy in patients with type 1 diabetes modifies CD4+CD25+FOXP3+ regulatory T-cells. Diabetes 57: 2341-2347.
29. Morelli AE, Larregina AT, Shufesky WJ, Sullivan ML, Stolz DB, et al. (2004) Endocytosis, intracellular sorting, and processing of exosomes by dendritic cells. Blood 104: 3257-3266.
30. Wang GJ, Liu Y, Qin A, Shah SV, Deng ZB, et al. (2008) Thymus exosomes-like particles induce regulatory T cells. J Immunol 181: 5242-5248.
31. Cai Z, Zhang W, Yang F, Yu L, Yu Z, et al. (2012) Immunosuppressive exosomes from TGF-β1 gene-modified dendritic cells attenuate Th17-mediated inflammatory autoimmune disease by inducing regulatory T cells. Cell Res 22: 607-610.
32. Muthana M, Fairburn B, Mirza S, Slack LK, Pockley AG, (2004) Systematic evaluation of the conditions required for the generation of immature rat bone marrow-derived dendritic cells and their phenotypic and functional characterization. J Immunol Methods 294(1-2): 165-179.
33. Niimi M, (2001) The technique for heterotopic cardiac transplantation in mice: experience of 3000 operations by one surgeon. J Heart Lung Transplant 20: 1123-1128.
34. Chen ZH, (1991) A technique of cervical heterotopic heart transplantation in mice. Transplantation 52: 1099-1101.